• Legislative Update Week Ending November 21 2014

    Pre-Election Recess Continues .New Medicare Enrollees in 201Because these people are new to Medicare, they pay the full amount in 2017 when they sign up. .How do you envision your perfect day in retirement? Are you the type that needs to be busy with work and projects to feel fulfilled, or do you look forward to spending time puttering around on your own, traveling or just enjoying leisure? Note how you like to spend your time. … Continued

  • Ask The Advisor June 2011 Advisor Feed

    Doing nothing and allowing the Social Security recipients to go with just a 1.3% COLA, would be highly detrimental to the Social Security income of all retirees, and would not extend program solvency. TSCL is working to make Members of Congress aware of the need for providing this boost to your Social Security benefits both to strengthen your retirement income and to protect you from huge spikes in the Medicare Part B premium. .Shopping For a Better Drug Plan NOW Can Put More Money in Your 2020 Budget .According to the committee's report, AbbVie has raked in more than 0 billion in net revenue from those two drugs since 2013, which the committee said was "driven in large part by AbbVie executives' decision to repeatedly raise the prices of Humira and Imbruvica." The company's top executives pocketed 0 million in compensation during that span, "much of which was directly linked to revenue increases," the report said. … Continued

Rural Americans who face unique challenges would also experience unique struggles under a one-size-fits-all healthcare plan. For years, the farmers, ranchers, and everyone living in our nation's breadbasket have endured inequitable access to quality care and medical services compared to their urban and suburban counterparts. .On Tuesday evening, President Obama gave his fifth State of the Union Address before both chambers of Congress. To The Senior Citizens League's (TSCL's) surprise, the sixty-five minute speech included no mention of Social Security or Medicare, but the President did speak briefly about immigration reform and a new retirement savings plan called "myRA." .While most people have rebounded, too many mature workers are still struggling to find work, much less a good-paying job. According to a survey by AARP, half of mature workers who experienced unemployment between 2010-2014 were still looking for work five years later. .As a result of the inadequate funding, both the both the Old-Age and Survivors Insurance (OASI) and the Disability Insurance (DI) programs have been struggling to serve the public. More than one million applicants are currently waiting to hear whether they qualify for DI benefits, and those who have appealed recent rejections must wait 600 days or longer for their cases to be re-heard. In 2017, 10,000 individuals died while waiting on their DI eligibility decisions. While waiting, they had no access to DI benefits or Medicare coverage, which recipients with long-term disabilities can receive after they are enrolled in the program for two years. .But that's not the case for about 12 million employees with the highest salaries in the country. Unlike the Medicare payroll tax, which applies to all earnings, Social Security payroll taxes apply only to the first 8,400 in earnings. Neither the employees who earn more than 8,400, nor their employers, pay Social Security taxes on earnings in excess of that amount. "That's a problem for Social Security's financing," says Johnson. ."Our example just looked at the salaries and performance pay of just 20 CEOs," notes Johnson. "According to the Social Security Administration, there will be 12 million people who earn above the taxable maximum in 2018," she adds. .SSA Rescinds New Online Security Policy .This week, TSCL endorsed two new bills from Congressman Lloyd Doggett (TX-35) – the Transparent Drug Pricing Act (H.R. 4116) and the Competitive DRUGS Act (H.R. 4117). If signed into law, the bills would promote transparency in the prescription drug industry and prevent anti-competitive pay-for-delay deals, in which brand-name drug companies pay generic drug makers millions of dollars to delay the introduction of their generic medicines to the market. .Such logic would be disastrous if it were applied to a successful COVID vaccine. COVID-19 has shut down countless businesses, creating record-high unemployment. And the medical consequences of severe COVID-19 mean weeks of highly expensive intensive care.